Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus
- Resource Type
- Article
- Source
- In
Diabetes Research and Clinical Practice January 2019 147:157-165 - Subject
- Language
- ISSN
- 0168-8227